Hyun Jin Bae began working as a Post-doc at Harvard Medical School in February 2015 and remained in that role until March 2020. In March 2020, they joined LegoChem Biosciences as a Senior Research Scientist, and their employment there is ongoing.
Hyunjin Bae has an impressive education history. 현진 started their academic journey at Sungkyunkwan University, where they pursued a Master of Science (M.S.) in Biochemistry from 2000 to 2007. Following this, they went on to enroll at The Catholic University of Korea, where they completed a Doctor of Philosophy (PhD) in Tumor Biology from 2007 to 2013.
This person is not in any offices
LegoChem Biosciences
LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of innovative medicines by leveraging our chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).